New data finds older patients with severe aortic stenosis (AS) were more likely to receive aortic valve replacement (AVR) and ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--egnite, Inc., a leading cardiovascular digital health company, today announced the results of its seminal research on the real-world impact of clinical ...
Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in ...
Background: The incidence of conduction disease requiring permanent pacemaker (PPM) implantation following aortic valve replacement (AVR) ranges from 3% to 6%. Data concerning the potential risks for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results